Steven Stetson
Ophthalmology · New York, NYNPI 1487603411
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,603 of the $6,603 with a category attached, or 84.9%. It is spread thinly across 22 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,997 and has fallen 62.5% since, to $750 in 2025.
Across 178 payments — averaging $37.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Glaukos Corporation$1K
- Nidek Incorporated$1K
- Sun Pharmaceutical Industries Inc.$953
- Oyster Point Pharma, Inc.$561
- Kala Pharmaceuticals, Inc.$362
- Johnson & Johnson Surgical Vision, Inc.$303
- plus $2K from 16 others
What the payments were for
- Speaking & faculty fees$1,00015%
- Food & beverage$5,60385%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Glaukos Corporation | 11 | $1,068 |
| Nidek Incorporated | 1 | $1,000 |
| Sun Pharmaceutical Industries Inc. | 48 | $953 |
| Oyster Point Pharma, Inc. | 17 | $561 |
| Kala Pharmaceuticals, Inc. | 17 | $362 |
| Johnson & Johnson Surgical Vision, Inc. | 4 | $303 |
| Novartis | 19 | $286 |
| Bausch & Lomb Americas Inc. | 13 | $266 |
| Sight Sciences, Inc. | 4 | $257 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 11 | $242 |
| Shire North American Group Inc | 17 | $196 |
| Alcon | 3 | $185 |
| Rxsight Inc | 1 | $156 |
| Tarsus Pharmaceuticals, Inc. | 2 | $155 |
| Carl Zeiss Meditec, Inc. | 2 | $147 |
| Omeros Corporation | 1 | $125 |
| Eyepoint US, Inc. | 1 | $125 |
| Ivantis, Inc | 1 | $105 |
| AbbVie | 2 | $37 |
| Dompe US, Inc. | 1 | $27 |
| Rayner Intraocular Lenses Limited | 1 | $24 |
| Eyevance Pharmaceuticals LLC | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KXL System$350
- CEQUA$250
- Photrexa Viscous and Photrexa$206
- CE-marked KXLA system$198
- RXSIGHT CONTACT LENS$156
- RXSIGHT INJECTOR CARTRIDGE$156
- RXSIGHT INJECTOR HANDPIECE$156
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$156
- RXSIGHT LIGHT ADJUSTABLE LENS (RXLAL)$156
- Wavelight Refractive Suite$150
- Photrexa$145
- TYRVAYA$136
- Tecnis IOL$134
- VisuMax$133
- OMIDRIA$125
- DEXYCU$125
- STAR S4 IR$119
- OMNI(R) SURGICAL SYSTEM (US)$115
- Hydrus Microstent$105
How this compares
$6,603 in reported general payments places this provider in the 85th percentile of 1,587 ophthalmology providers in New York.
Other ophthalmology in New York
- Nathan RadcliffeNew York$2.1M
- Richard SpaideNew York$1.7M
- Joshua YoungNew York$814K
- Joseph PanarelliNew York$541K
- Eric RosenbergNew York$434K
- Michael CooneyNew York$398K
- David GuyerNew York$322K
- Ashley BrissetteNew York$315K
- Jason SlakterNew York$272K
- David ChuNew York$234K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.